| View |
|
DR-XY35200
|
Fluticasone furoate
|
Avamys
|
27.5 mg/actuation
|
Suspension For Nasal Spray
|
Corticosteroid
|
Glaxo Operations UK Ltd.
|
United Kingdom
|
Renewal
|
07 November 2023
|
03 December 2028
|
| View |
|
DR-XY35204
|
Pemetrexed (as disodium)
|
Alimta
|
100 mg
|
Powder for Concentrate for Solution for Infusion
|
Anti-metabolite (Folic Acid Analogue)
|
Vianex S.A. - Plant C
|
Greece
|
Renewal
|
09 August 2023
|
03 December 2028
|
| View |
|
DR-XY35206
|
Divalproex sodium (equivalent to Valproic Acid)
|
ZYSTAL
|
250 mg
|
Film-Coated Tablet
|
Antiepileptic
|
Hansel Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
19 December 2023
|
05 December 2028
|
| View |
|
DR-XY35220
|
Ascorbic Acid (as Sodium Ascorbate)
|
Carezee
|
100mg/ mL
|
Syrup (Oral Drops)
|
Vitamins
|
J.M. Tolamnn Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
10 January 2022
|
10 December 2026
|
| View |
|
DR-XY35222
|
Biperiden hydrochloride
|
Aketon
|
2mg
|
Tablet
|
Anticholinergic
|
Yoo Young Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
19 December 2023
|
11 December 2028
|
| View |
|
DR-XY35226
|
0.9% Sodium Chloride
|
A.N.B.
|
900 mg/100 mL
|
Solution for Intravenous Infusion (IV)
|
-
|
A.N.B. Laboratories Co., Ltd.
|
Thailand
|
Initial (Variation) (Correction)
|
12 October 2023
|
04 September 2028
|
| View |
|
DR-XY35227
|
Sodium Chloride
|
A.N.B. Sodium Chloride Normal Saline Solution
|
0.9% (900mg/100mL)
|
Normal Saline Solution
|
-
|
A.N.B. Laboratories Company Limited
|
Thailand
|
-
|
02 February 2021
|
15 December 2025
|
| View |
|
DR-XY35228
|
Mannitol
|
A.N.B. Mannitol
|
20mg/mL (20% w/v)
|
Solution for IV Infusion
|
-
|
A.N.B. Laboratories Company Limited
|
Thailand
|
Automatic Renewal
|
17 February 2021
|
15 December 2025
|
| View |
|
DR-XY35229
|
Sterile Water For Injection
|
A.N.B.
|
none
|
Sterile Water for Injection (Solution)
|
-
|
A.N.B. Laboratories Co. Ltd.
|
Thailand
|
-
|
11 March 2021
|
15 December 2025
|
| View |
|
DR-XY35231
|
Orlistat
|
Lesofat
|
60 mg
|
Capsule
|
Anti-Obesity
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
04 August 2023
|
15 December 2028
|
| View |
|
DR-XY35232
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Mintribee-100
|
100 mg/5 mg/50 mcg
|
Film-Coated Tablet
|
Vitamin
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
14 March 2019
|
15 December 2028
|
| View |
|
DR-XY35243
|
Sodium Chloride
|
Salacyn
|
9mg/ mL (0.9% w/ v)
|
Sterile Ophthalmic Solution (Drops)
|
Irrigant
|
Laboratorios Ashford LDA.
|
China
|
Renewal
|
04 August 2024
|
19 December 2030
|
| View |
|
DR-XY35252
|
Cefpodoxime Proxetil
|
Trizef
|
50 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
15 August 2023
|
23 December 2028
|
| View |
|
DR-XY35257
|
Paclitaxel
|
Paxel
|
100mg/ 16.7mL
|
Solution for Injection (IV)
|
Cell Cycle-Specific Agent
|
Intas Pharmaceutical Ltd.
|
India
|
Automatic Renewal
|
11 January 2022
|
23 December 2026
|
| View |
|
DR-XY35265
|
Salmeterol Xinafoate + Fluticasone Propionate
|
Salmeflo
|
25mcg/250mcg
|
Metered Dose Inhaler
|
Selective Beta-2 Adrenoreceptor Agonist Corticosteroid
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
21 December 2023
|
05 January 2029
|
| View |
|
DR-XY35268
|
Pilocarpine Hydrochloride
|
Piloptic-2
|
20mg/ mL (2% w/ v)
|
Ophthalmic Solution
|
-
|
Laboratorios Ashford LDA.
|
China
|
-
|
21 April 2021
|
05 January 2026
|
| View |
|
DR-XY35277
|
Cetirizine Dihydrochloride
|
Ceti-Med
|
10 mg
|
Film-Coated Tablet
|
H1-Receptor Antagonists (Antihistamines)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
12 February 2019
|
07 January 2029
|
| View |
|
DR-XY35284
|
Cefuroxime (as sodium)
|
Fumerix-250
|
250 mg
|
Powder For Injection (Im/Iv)
|
Antibacterial (Cephalosporin)
|
PharmEvo (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
05 February 2024
|
09 January 2029
|
| View |
|
DR-XY35285
|
Desmopressin (as acetate)
|
Minirin Melt
|
60 mcg
|
Oral Lyophilisate
|
Posterior Pituitary Hormone
|
Catalent U.K. Swindon Zydis Ltd.
|
United Kingdom
|
Renewal
|
21 December 2023
|
09 January 2029
|
| View |
|
DR-XY35289
|
Memantine HCl
|
Zimerz
|
10mg
|
Film-Coated Tablet
|
Anti-Parkinsonism
|
I1dong Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
04 August 2024
|
21 July 2030
|